Clinical Trial Update: Effectiveness of Trivalent Influenza Vaccine (TIV) in Type 2 Diabetes Mellitus (T2DM) Patients With and Without Complications of Chronic Kidney Disease (CKD) [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the effectiveness of a trivalent influenza vaccine in patients with type 2 diabetes, with and without chronic kidney disease com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Trivalent influenza vaccine (Influenza vaccine, trivalent)

Snippet

Sponsor: Universitas Padjadjaran | Conditions: Influenza, Vaccine Reaction | Phase 4 | Status: COMPLETED